Metraipolis › archive › dc_98f5fd771ac2

Albiflorin-Mediated MAP2K1 Targeting and HIF-1 Signaling Inhibition Contribute to the Therapeutic Efficacy in Hyperuricemia-Associated Cognitive Impairment — Europe PMC PMID:41561638

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41561638
DOI
10.1155/humu/5859468
License (as archived)
solo-consultazione
Archived
2026-11-06T17:15:59.466Z
SHA-256 of the archived text
6e45e4df536cb9463a7ac7805956972729294972f49c282284cbe6435b4a2326
Stable URL of this page
https://metraipolis.com/documento/dc_98f5fd771ac2

How to cite

Albiflorin-Mediated MAP2K1 Targeting and HIF-1 Signaling Inhibition Contribute to the Therapeutic Efficacy in Hyperuricemia-Associated Cognitive Impairment — Europe PMC PMID:41561638 — Europe PMC (en), https://europepmc.org/article/MED/41561638 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98f5fd771ac2 (Metraipolis archive dc_98f5fd771ac2, sha256 6e45e4df536cb9463a7ac7805956972729294972f49c282284cbe6435b4a2326)
BibTeX
@misc{dc98f5fd771ac2,
  title = {Albiflorin-Mediated MAP2K1 Targeting and HIF-1 Signaling Inhibition Contribute to the Therapeutic Efficacy in Hyperuricemia-Associated Cognitive Impairment — Europe PMC PMID:41561638},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41561638},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98f5fd771ac2; sha256 6e45e4df536cb9463a7ac7805956972729294972f49c282284cbe6435b4a2326},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41561638. Agents can read the archived copy with the MCP tool read_document.